Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.

@article{Gurakar1985LevelsOL,
  title={Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.},
  author={Ahmet O Gurakar and Jeffrey M. Hoeg and Gert M. Kostner and Nick M. Papadopoulos and Hollis B Brewer},
  journal={Atherosclerosis},
  year={1985},
  volume={57 2-3},
  pages={293-301}
}
Total and low density lipoprotein cholesterol concentration reduction in patients with markedly increased levels of these substances, leads to a decline in the incidence of myocardial infarction and death. A unique cholesterol-rich lipoprotein, lipoprotein Lp(a), has been identified which not only can be confused with low density lipoproteins, but has also been associated with premature cardiovascular disease. Using the cholesterol-lowering drugs neomycin and niacin in 14 type II… CONTINUE READING